Polyclonal versus monoclonal immunoglobulin-free light chains quantification

Annals of Clinical Biochemistry

Volumn 52, Issue 3, 2015, Pages 327-336

  Di Noto, Giuseppe ^a   Cimpoies, Elena ^a   Dossi, Alessandra ^a   Paolini, Lucia ^a   Radeghieri, Annalisa ^a   Caimi, Luigi ^a   Ricotta, Doris ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

dimers; Monoclonal component; monomers; plasma cell dyscrasia; serum free light chain

Indexed keywords

IMMUNOGLOBULIN; PARAPROTEIN; POLYCLONAL IMMUNOGLOBULIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FREELITE ASSAY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; N LATEX FREE LIGHT CHAIN ASSAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; WESTERN BLOTTING; BLOOD; COMPARATIVE STUDY; IMMUNOASSAY; STANDARDS;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN LIGHT CHAINS;

EID: 84930428423     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214553808     Document Type: Article

References (22)

1. Dispenzieri A,Kyle R,Merlini G, et al.International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.Leukemia. 2009;23:215-244
2. Bradwell AR,Carr-Smith HD,Mead GP, et al.Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.Clin Chem. 2001;47:673-804
3. Rao M, Lamont JL, Chan J, et al. Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias: future research needs: identification of future research needs from comparative effectiveness Review No. 73. Report No.: 12-EHC135-EF, September 2012. Rockville, MD: Agency for Healthcare Research and Quality (US).
4. Dispenzieri A,Katzmann JA,Kyle RA, et al.Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.Mayo Clin Proc. 2012;87:517-523
5. Marshall G,Tate J,Mollee P.Borderline high serum free light chain κ/λ ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory states.Am J Clin Pathol. 2009;132:309-309
6. Anandram S,Assi LK,Lovatt T, et al.Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study.J Clin Pathol. 2012;65:1036-1042
7. Velthuis H,Knop I,Stam P, et al.N Latex FLC – new monoclonal high-performance assays for the determination of free light chain kappa and lambda.Clin Chem Lab Med. 2011;49:1323-1332
8. Lock RJ,Saleem R,Roberts EG, et al.A multicentre study comparing two methods for serum free light chain analysis.Ann Clin Biochem. 2013;50:255-255
9. Kyle RA,Durie BGM,Rajkumar SV, et al.Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.Leukemia. 2010;24:1121-1127
10. Rajkumar SVUpToDate. Basow DS, ed. Waltham: UpToDate; 2011:
11. Kaplan B,Livneh A,Sela BA.Immunoglobulin free light chan dimers in human diseases.Scientific World Journal. 2011;11:726-735
12. Katzmann JA,Clark RJ,Abraham RS, et al.Serum reference intervals and diagnostic ranges for free k and free λ immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.Clin Chem. 2002;48:1437-1444
13. Hoedemakers RM,Pruijt JF,Hol S, et al.Clinical comparison of new monoclonal antibody based assay for free light chain kappa and lambda to polyclonal antibody based assays and immunofixation electrophoresis.Clin Chem Lab Med. 2011;50:489-495
14. Abadie JM,van Hoeven KH,Wells JM.Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?.Am J Clin Pathol. 2009;131:166-171
15. Bland JM,Altman DG.Measuring agreement in method comparison studies.Stat Methods Med Res. 1999;8:135-160
16. Wetenhall K,Saleem R,Rowbottom A.Detection of free light chain monoclonal protein comigrating with intact monoclonal proteins in patients with monoclonal gammopathy.Ann Clin Biochem. 2012;49:603-605
17. Vercammen M,Meirlaen P,Broodtaerts L, et al.Effect of sample dilution on serum free light chain concentration by immunonephelometric assay.Clin Chim Acta. 2011;412:1798-1804
18. Jenner E.Serum free light chains in clinical laboratory diagnostics.Clin Chim Acta. 2014;427:15-20
19. Kaplan B1,Golderman S,Aizenbud B, et al.Immunoglobulin free light chain monomer-dimer patterns help to distinguish malignant from pre-malignant monoclonal gammopathies: a pilot study.Am J Hematol. 2014;89:882-888
20. Li C,Geng H,Yang Z, et al.Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay.Clin Lab. 2011;57:53-57
21. Abraham RS,Charlesworth MC,Owen BA, et al.Trimolecular complexes of lambda light chain dimer in serum of a patient with multiple myeloma.Clin Chem. 2002;48:1805-1810
22. Sølling K,Sølling J,Lanng Nielsen J.Polymeric Bence Jones proteins in serum in myeloma patients with renal insufficiency.Acta Med Scand. 1984;216:495-502